[go: up one dir, main page]

AU3079692A - Using the immunoactivating activity of 3-naphthyloxy-2-hydroxy-propylamines, in particular for providing cell immunity, e.g. against viral infections - Google Patents

Using the immunoactivating activity of 3-naphthyloxy-2-hydroxy-propylamines, in particular for providing cell immunity, e.g. against viral infections

Info

Publication number
AU3079692A
AU3079692A AU30796/92A AU3079692A AU3079692A AU 3079692 A AU3079692 A AU 3079692A AU 30796/92 A AU30796/92 A AU 30796/92A AU 3079692 A AU3079692 A AU 3079692A AU 3079692 A AU3079692 A AU 3079692A
Authority
AU
Australia
Prior art keywords
propylamines
naphthyloxy
hydroxy
viral infections
cell immunity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30796/92A
Inventor
Karin Elisabeth Peuschel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3079692A publication Critical patent/AU3079692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU30796/92A 1991-12-20 1992-12-14 Using the immunoactivating activity of 3-naphthyloxy-2-hydroxy-propylamines, in particular for providing cell immunity, e.g. against viral infections Abandoned AU3079692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH3795/91 1991-12-20
CH379591 1991-12-20

Publications (1)

Publication Number Publication Date
AU3079692A true AU3079692A (en) 1993-07-28

Family

ID=4263624

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30796/92A Abandoned AU3079692A (en) 1991-12-20 1992-12-14 Using the immunoactivating activity of 3-naphthyloxy-2-hydroxy-propylamines, in particular for providing cell immunity, e.g. against viral infections

Country Status (5)

Country Link
EP (1) EP0587823A1 (en)
AU (1) AU3079692A (en)
CA (1) CA2109224A1 (en)
FI (1) FI935056A0 (en)
WO (1) WO1993013049A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013761A (en) * 1988-06-03 1991-05-07 Eli Lilly And Company Serotonin antagonists
GB0023467D0 (en) * 2000-09-25 2000-11-08 Btg Int Ltd Amine compounds
CN107556203B (en) * 2016-06-30 2022-05-03 康普药业股份有限公司 Preparation method of propranolol
CN113336656B (en) * 2021-05-28 2022-03-01 常州康普药业有限公司 Method for synthesizing propranolol hydrochloride
US11998013B1 (en) 2023-09-01 2024-06-04 King Faisal University 1-(morpholin-4-yl)-3-(naphthalen-2-yloxy)propan-2-ol as an eco-friendly insecticidal agent against spodoptera littoralis (boisd.)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026897A (en) * 1974-01-31 1977-05-31 Otsuka Pharmaceutical Company 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxycarbostyril derivatives
US4329502A (en) * 1978-08-28 1982-05-11 Syva Company Propranolol antigen conjugates and antibodies
DE3066975D1 (en) * 1980-08-04 1984-04-19 Syva Co Propranolol antigen conjugates and antibodies and method of using them
US4652681A (en) * 1982-04-15 1987-03-24 Drug Science Foundation Aminoalkoxy derivatives of propranolol for immunoassay applications
US4472301A (en) * 1982-05-27 1984-09-18 Miles Laboratories, Inc. Propranolol immunogen and antibodies
PT87163B (en) * 1987-04-09 1992-07-31 Lilly Co Eli 1-PHENYL-3-NAFTALENYLXY-PROPANAMINES PREPARATION

Also Published As

Publication number Publication date
WO1993013049A1 (en) 1993-07-08
FI935056A0 (en) 1993-11-15
EP0587823A1 (en) 1994-03-23
CA2109224A1 (en) 1993-06-21

Similar Documents

Publication Publication Date Title
AU6194094A (en) Sweetener, process for the preparation thereof and the use thereof
EP0600470A3 (en) Bipolar membrane.
EP0584245A4 (en) Enzyme systems.
AU2231488A (en) Composition suitable for use as, or in, an acidic rinse aid
AU9075591A (en) N-halochitosans, their preparation and uses
AU1704588A (en) Amino-9,10-secosteroids
AU2056792A (en) Means for the conveyance of produce, particularly fruit
AU1454188A (en) 3-substituted 1-(2-chlorothiazol-5-yl-methyl)-2-nitroimino- 1,3-diazacycloalkanes
GR3025747T3 (en) Device for the culture of molluses, in particular of oysters.
IL109963A0 (en) E2-f1 enzyme and methods for the isolation, purification and use thereof
AU620688B2 (en) Aseptically-packaged, aspartame-containing puddings
AU3999785A (en) Laminates, particularly mirror laminates
AU1738192A (en) LFA-3-like protein, derivatives thereof, genes thereof and processes for preparing the same
AU5922694A (en) 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use
AU4511489A (en) 14alpha,17alpha-ethano-estratrienes
AU3079692A (en) Using the immunoactivating activity of 3-naphthyloxy-2-hydroxy-propylamines, in particular for providing cell immunity, e.g. against viral infections
AU1959488A (en) (n-alpha-acyl, 8-glycine, des-19-leucine)-calcitonin
EP0646342A3 (en) Chair.
AU566917B2 (en) 5-oxo-2,4-dichloro-4-substituted pentanenitriles
AU2353092A (en) Substituted aminopropanes, processes for their preparation, and their use
AU1059692A (en) Membranes
AU2406684A (en) Hexanor-brassinolidine-22-ethers, i.e. 6-or7-oxa-b- homosteroids
AU6191086A (en) Dispenser, in particular for milk or the like
AU3205893A (en) New 4-cinnolinyl- and 4-naphthyridinyl-dihydropyridines, processes for their use in medicaments
AU1517888A (en) Des-19-leucine, 20-glutamine, 21-threonine, 22-tyrosine-calcitonin